C260-1909 Screening compound: 2-[4-(1-{[(4-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-[(oxolan-2-yl)methyl]acetamide

C260-1909 Screening compound: 2-[4-(1-{[(4-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-[(oxolan-2-yl)methyl]acetamide
C260-1909 Screening compound: 2-[4-(1-{[(4-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-[(oxolan-2-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-1909
2-[4-(1-{[(4-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-[(oxolan-2-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-1909

Molecular Formula

C30H30N4O6 (C30 H30 N4 O6)

Compound Name

2-[4-(1-{[(4-methoxyphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)phenyl]-N-[(oxolan-2-yl)methyl]acetamide

IUPAC name

2-[4-(1-{[(4-methoxyphenyl)carbamoyl]methyl}-24-dioxo-1234-tetrahydroquinazolin-3-yl)phenyl]-N-[(oxolan-2-yl)methyl]acetamide

SMILES

COc(cc1)ccc1NC(CN(c(cccc1)c1C(N1c2ccc(CC(NCC3OCCC3)=O)cc2)=O)C1=O)=O

InChI

InChI=1S/C30H30N4O6/c1-39-23-14-10-21(11-15-23)32-28(36)19-33-26-7-3-2-6-25(26)29(37)34(30(33)38)22-12-8-20(9-13-22)17-27(35)31-18-24-5-4-16-40-24/h2-3,6-15,24H,4-5,16-19H2,1H3,(H,31,35)(H,32,36)/t24-/m1/s1

InChI Key

GBGSKXVTLWBQRC-XMMPIXPASA-N

MDL Number (MFCD)

MFCD14738245

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

542.59

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.722

Distribution Coefficient, logD

1.722

Water Solubility, LogSw

-2.65

Polar Surface Area

94.203

Acid Dissociation Constant (pKa)

12.61

Base Dissociation Constant (pKb)

4.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

26.70

C260-1909 in Drug Discovery

Included in Screening Libraries

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C260-1909 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-1909?
Check Price and Availability of C260-1909, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-1909 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-1909
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-1909
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-1909 available by request